Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 47Polycystic Ovary Syndrome 6Infertility 2Hyperandrogenism 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Prostatic Intraepithelial Neoplasia 1Prostate Adenocarcinoma 1Primary Dysautonomias 1Overweight 1Ovarian Neoplasms 1Oligomenorrhea 1Neoplasm Metastasis 1Metabolic Syndrome 1Kidney Diseases 1Insulin Resistance 1Hypertension 1Hirsutism 1Castration-resistant Prostate Cancer 1Carcinoma, Ovarian Epithelial 1Anovulation 1Amenorrhea 1Adenocarcinoma 1

Interventions

bicalutamide 2Mifepristone 2Metformin 2Corlux 2drospirenone and ethinyl estradiol combination 1Magnesium 1Folic Acid 1Flutamide 1Ethinyl Estradiol 1Cyproterone acetate, ethinyl estradiol drug combination 1Cyproterone Acetate 1Carnitine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hirsutism × Flutamide × Clear all
NCT01889199 2025-01-10

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

University of California, Los Angeles

Phase 2 Completed
23 enrolled 12 charts

Amenorrhea, Anovulation, Hirsutism, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡